SLC16A1 and rhabdomyosarcoma: Phorbol 12-myristate 13-acetate, a PKC activator, was shown to increase lactic acid uptake in rhabdomyosarcoma cells as well as to increase MCT1 protein and mRNA levels (Narumi et al. 2010).